Supriya Lifescience (NSE:SUPRIYA) FFO


NSE:SUPRIYA Supriya Lifescience Ltd NSE:SUPRIYA
75 GF Score
Price ₹978.90
GF Value ₹805.46
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Supriya Lifescience FFO?

FFO (Funds from operations) only applies to REITs.

NSE:SUPRIYA
75GF Score
Supriya Lifescience Ltd NSE:SUPRIYA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Supriya Lifescience (NSE:SUPRIYA) Overvalued in 2026?

Based on GuruFocus' analysis, Supriya Lifescience stock appears to be overvalued. The current stock price of ₹978.90 is trading 21.5% above its estimated GF Value™ of ₹805.46. GuruFocus considers Supriya Lifescience to be Modestly Overvalued.

Key valuation signals for NSE:SUPRIYA:

  • FFO:
  • GF Value™: ₹805.46 vs. price of ₹978.90 (21.5% above fair value)
  • GF Score™: 75/100 with 8 warning signs

No single metric tells the full story. See the NSE:SUPRIYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Supriya Lifescience Business Description

Other Exchanges 543434:India
Address Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
75GF Score

Get the complete analysis for NSE:SUPRIYA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹978.90
Price
₹805.46
GF Value